HOPU Investment Management Company also known as the HOPU Fund is a private equity investment firm that conducts investments in China.
HOPU Jinghua (Beijing) Investment Management Company Limited is a private equity investment firm formed in 2008 by former Goldman Sachs China partner Fang Fenglei, former Goldman Sachs Co-Head of Investment Banking (excluding Japan) Richard Ong, and former KPMG Chair Dominic Ho. It raised its first fund in 2008 and went on hiatus in 2011. In 2013, HOPU re-entered the private equities market and raised a new fund with plans to expand even more.
Announced Date | Fund Name | Money Raised | |
---|---|---|---|
Feb 8, 2018 | US dollar-denominated Fund III | $2B |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 24, 2021
Lyndra Therapeutics
|
Series C | $60.50M | Biotechnology | — |
Apr 21, 2021
Shumei Technology
|
Series D | $135M | Artificial Intelligence | — |
Jan 22, 2021
4Paradigm
|
Series D | $700M | Artificial Intelligence | Yes |
Mar 31, 2020
Yatsen Holding
|
Series D | $240M | Beauty | — |
Feb 4, 2020
Ceva Santé Animale
|
Series Unknown | — | Biotechnology | — |
HOPU Investment Management Company has had 10 exits. HOPU Investment Management Company most notable exits include NIO , SenseTime
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
May 20, 2022 | NIO | IPO | Automotive | Detail |
Dec 30, 2021 | SenseTime | IPO | Artificial Intelligence | Detail |
Jun 18, 2021 | Ambrx | IPO | Biopharma | Detail |
Nov 19, 2020 | Yatsen Holding | IPO | Beauty | Detail |
Jan 16, 2020 | I-Mab Biopharma | IPO | Biotechnology | Detail |